First test of new lupus shot begins in humans
NCT ID NCT06144710
Summary
This is the first study in people for a new potential lupus treatment called SG301. It aims to first check the safety of a single dose in healthy volunteers, and then test multiple doses in people with mild-to-moderate lupus. The main goal is to see how safe the drug is and how the body processes it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Affiliated Hospital of Xiamen University
Xiamen, Fujian, 361003, China
-
Huashan Hospital affiliated to Fudan University
Shanghai, Shanghai Municipality, 200040, China
-
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, 330006, China
-
Jining First People's Hospital
Jining, Shandong, 272002, China
-
Pingxiang People's Hospital
Pingxiang, Jiangxi, 337099, China
-
Shandong University Qilu Hospital
Jinan, Shandong, 250063, China
-
Shenzhen People's Hospital
Shenzhen, Guangdong, 518020, China
-
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, 233000, China
-
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, 350004, China
-
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, 314408, China
Conditions
Explore the condition pages connected to this study.